{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:53:04Z","timestamp":1767495184446,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1038\/s41409-021-01282-1","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T21:03:13Z","timestamp":1617742993000},"page":"1757-1760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["T-cell replete haploidentical transplantation with reduced post-transplant cyclophosphamide in six children with infantile osteopetrosis"],"prefix":"10.1038","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6509-8526","authenticated-orcid":false,"given":"Amal","family":"Al-Seraihy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hawazen","family":"Al-Saedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8732-5611","authenticated-orcid":false,"given":"Ali","family":"Al-Ahmari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Ghemlas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5740-1302","authenticated-orcid":false,"given":"Mouhab","family":"Ayas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"key":"1282_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1182\/blood-2015-01-625541","volume":"126","author":"PJ Orchard","year":"2015","unstructured":"Orchard PJ, Fasth AL, Le Rademacher J, He W, Boelens JJ, Horwitz EM, et al. Hematopoietic stem cell transplantation for infantile osteopetrosis. Blood. 2015;126:270\u20136.","journal-title":"Blood"},{"key":"1282_CR2","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.bbmt.2016.07.015","volume":"22","author":"R Chiesa","year":"2016","unstructured":"Chiesa R, Ruggeri A, Paviglianiti A, Zecca M, Gonzalez-Vicent M, Bordon V, et al. Outcomes after unrelated umbilical cord blood transplantation for children with steopetrosis. Biol Blood Marrow Transpl. 2016;22:1997\u20132002.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1282_CR3","doi-asserted-by":"publisher","first-page":"431923","DOI":"10.1155\/2015\/431923","volume":"2015","author":"SR McCurdy","year":"2015","unstructured":"McCurdy SR, Fuchs EJ. Comparable outcomes for hematologic malignancies after HLA-haploidentical transplantation with post transplantation cyclophosphamide and HLA-matched transplantation. Adv Hematol. 2015;2015:431923.","journal-title":"Adv Hematol"},{"key":"1282_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.bbmt.2016.02.001","volume":"22","author":"OR Klein","year":"2016","unstructured":"Klein OR, Chen AR, Gamper C, Loeb D, Zambidis E, Llosa N, et al. Alternative-donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for nonmalignant disorders. Biol Blood Marrow Transpl. 2016;22:895\u2013901.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1282_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/pbc.25801","volume":"63","author":"J Natsheh","year":"2016","unstructured":"Natsheh J, Drozdinsky G, Simanovsky N, Lamdan R, Erlich O, Gorelik N, et al. Improved outcomes of hematopoietic stem cell transplantation in patients with infantile malignant osteopetrosis using fludarabine-based conditioning. Pediatr Blood Cancer. 2016;63:535\u201340.","journal-title":"Pediatr Blood Cancer"},{"key":"1282_CR6","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1182\/blood.V99.9.3458","volume":"99","author":"AS Schulz","year":"2002","unstructured":"Schulz AS, Classen CF, Mihatsch WA, Sigl-Kraetzig M, Wiesneth M, Debatin KM, et al. HLA-haploidentical blood progenitor cell transplantation in osteopetrosis. Blood. 2002;99:3458\u201360.","journal-title":"Blood"},{"key":"1282_CR7","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1182\/blood.V124.21.5935.5935","volume":"124","author":"CJ Pronk","year":"2014","unstructured":"Pronk CJ, Turkiewicz D, Dykes J, Toporski J. Transplantation of maternal haploidentical TcR\u03b1\u03b2-depleted stem cells for malignant infantile osteopetrosis\u2013optimal timing and rapid hematological recovery. Blood. 2014;124:5935.","journal-title":"Blood"},{"key":"1282_CR8","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/bmt.2015.201","volume":"50","author":"F Porta","year":"2015","unstructured":"Porta F, Cavagnini S, Imberti L, Sottini A, Bolda F, Beghin A, et al. Partial depletion of TCR alpha\/beta+\/CD19+ cells in matched unrelated transplantation of three patients with osteopetrosis. Bone marrow Transpl. 2015;50:1583\u20135.","journal-title":"Bone marrow Transpl"},{"key":"1282_CR9","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/bmt.2016.180","volume":"51","author":"TL Bahr","year":"2016","unstructured":"Bahr TL, Lund T, Sando NM, Orchard PJ, Miller WP. Haploidentical transplantation with post-transplant cyclophosphamide following reduced-intensity conditioning for osteopetrosis: outcomes in three children. Bone Marrow Transpl. 2016;51:1546\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"1282_CR10","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.bbmt.2019.03.009","volume":"25","author":"B Neven","year":"2019","unstructured":"Neven B, Diana JS, Castelle M, Magnani A, Rosain J, Touzot F, et al. Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for primary immunodeficiencies and inherited disorders in children. Biol Blood Marrow Transpl. 2019;25:1363\u201373.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1282_CR11","doi-asserted-by":"publisher","first-page":"10871","DOI":"10.18632\/oncotarget.14719","volume":"8","author":"J Yuan","year":"2017","unstructured":"Yuan J, Pei R, Su W, Cao J, Lu Y. Meta-analysis of the actions of antithymocyte globulin in patients undergoing allogeneic hematopoietic cell transplantation. Oncotarget. 2017;8:10871\u20131082.","journal-title":"Oncotarget"},{"key":"1282_CR12","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1172\/JCI124218","volume":"129","author":"LP Wachsmuth","year":"2019","unstructured":"Wachsmuth LP, Patterson MT, Eckhaus MA, Venzon DJ, Gress RE, Kanakry CG. Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression. J Clin Invest. 2019;129:2357\u201373.","journal-title":"J Clin Invest"},{"key":"1282_CR13","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.bbmt.2019.07.010","volume":"25","author":"M Ayas","year":"2019","unstructured":"Ayas M, Siddiqui K, Al-Jefri A, Al-Ahmari A, Ghemlas I, Al-Saedi H, et al. Successful outcome in patients with Fanconi Anemia undergoing T cell-replete mismatched related donor hematopoietic cell transplantation using reduced-dose cyclophosphamide post-transplantation. Biol Blood Marrow Transpl. 2019;25:2217\u201321.","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-021-01282-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-021-01282-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-021-01282-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:18:49Z","timestamp":1684617529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01282-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1282"],"URL":"https:\/\/doi.org\/10.1038\/s41409-021-01282-1","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"assertion":[{"value":"29 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}